Replies to post #331774 on Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

from the annual report:

As of June 30, 2020, we had approximately $6.0 million in cash compared to $0.6 million of cash as of June 30, 2020, and as of the date of this filing, we have approximately $6.4 million in cash. We currently anticipate that future budget expenditures will be approximately $8.2 million for the fiscal year ending June 30, 2021, including approximately $6.2 million for clinical activities, supportive research, and drug product.

Not sure if the $6.2 is solely based on a B for C trial or includes other indications as well

[DrBones]

Also Leo stated that there was Demyan to hold the trial. Perhaps some grant work from the hospitals may be covering part of trial expenses?